A comprehensive dive into the contract research organization field offers a glimpse into how the virus has affected firms, and what the future might hold.
A leader from the contract research organization explains how home health personnel, decentralized trial technology and other services can help avoid study interruptions
The agency continues to offer advice related to drug development and clinical research during the pandemic, and take action against those falling out of line.
A leader from the clinical development services firm recommends clinical trials change their tack to avoid costly clinical trial interruptions in the face of the pandemic.
The clinical trial company launched the trial around cytokine storm, an immunological reaction associated with severe virus cases, in 15 business days.
The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.
A representative of the research and development firm offers perspective on how the industry has shifted in recent years, thanks to a number of forces.
The healthcare institution and life-sciences technology platform are working together to use artificial intelligence to detect and understand the virus.
The open-access resource, funded in part by the Bill and Melinda gates Foundation, is available to researchers, clinicians and others working on a cure.
A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.
The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.
The company’s global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began.
Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.
The pharmaceutical analysis firm is continuing its contract analytical laboratory services running, with changes designed to keep people and products safe.
Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.
The EndPandemic National Data Consortium has grown to six life-sciences and information-technology organizations, joining to collaborate on research data.
The health technology company is offering decentralized solutions enabling clinical trials for respiratory treatments to continue at participants’ homes.
